BVF Inc’s Sophiris Bio, Inc. SPHS Stock Holding History

BVF Inc’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,060,283	Closed	-$614K	–	35
2015 Q1	$614K	Hold	1,060,283	–	–	0.13%	29
2014 Q4	$573K	Buy	1,060,283 +460,283	+77%	+$1.07M	0.11%	31
2014 Q3	$1.76M	Hold	600,000	–	–	0.37%	25
2014 Q2	$1.34M	Hold	600,000	–	–	0.21%	27
2014 Q1	$2M	Hold	600,000	–	–	0.31%	20
2013 Q4	$2.22M	Hold	600,000	–	–	0.39%	21
2013 Q3	$2.81M	Buy	+600,000	New	+$2.77M	0.48%	22

Other funds holding SPHS

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BVF Inc's SPHS Position: Q2 2015 in Review

BVF Inc sold out of Sophiris Bio, Inc. (SPHS) in Q2 2015, closing a stake of 1,060,283 shares — an estimated $614K sold.

BVF Inc first reported a position in SPHS in Q3 2013 and held it in 7 quarters. The position peaked at $2.81M in Q3 2013. 18 funds tracked by Wall St. Rank hold SPHS as of Q2 2015.

BVF Inc reported no remaining Sophiris Bio, Inc. position as of Q2 2015 after selling out during the quarter.
BVF Inc sold 1,060,283 Sophiris Bio, Inc. shares in Q2 2015, an estimated $614K.
BVF Inc first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 7 quarters.
BVF Inc's Sophiris Bio, Inc. position peaked at $2.81M in Q3 2013.
18 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2015.

Based on BVF Inc's 13F filing for Q2 2015, filed 14 Aug 2015.